Previous Page TOC Index Next Page

8.10.3 CM1 - clinical study phase master segment

Each Clinical Study Phase Master (CM1) segment contains the information about one phase of a study identified in the preceding CM0. This is an optional structure to be used if the study has more than one treatment or evaluation phase within it. The identification of study phases that the patient enters are sent in the CSP segment: sequence 2. The CM1 segment describes the phase in general for the receiving system.

Figure 8-21. CM1 attributes

SEQ

LEN

DT

OPT

RP/#

TBL#

ITEM#

ELEMENT NAME

1

4

SI

R



01021

Set ID - CM1

2

60

CE

R



01022

Study Phase ID

3

300

ST

R



01023

Description of Study Phase

8.10.3.0 CM1 field definitions

8.10.3.1 Set ID - CM1 (SI) 01021

Definition: This field contains a number that uniquely identifies this transaction for the purpose of adding, changing, or deleting the transaction. For those messages that permit segments to repeat, the Set IF field is used to identify the repetitions.

8.10.3.2 Study phase ID (CE) 01022

Components: <identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier (ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>

Definition: This field should correspond to the study phase ID coding system in Section 7.7.2.1, "Study phase ID."

8.10.3.3 Description of study phase (ST) 01023

Definition: This field contains a brief explanation for recipients to understand what the phase represents.

Previous Page TOC Index Next Page